122 related articles for article (PubMed ID: 8780886)
1. Activation of tumor suppressor genes in nontumorigenic revertants of the HeLa cervical carcinoma cell line.
Boylan MO; Athanassiou M; Houle B; Wang Y; Zarbl H
Cell Growth Differ; 1996 Jun; 7(6):725-35. PubMed ID: 8780886
[TBL] [Abstract][Full Text] [Related]
2. The early genes E6 and E7 of cancer associated human papilloma viruses as targets of tumor suppression?
Bosch FX; Dürst M; Schwarz E; Boukamp P; Fusenig NE; zur Hausen H
Behring Inst Mitt; 1991 Jul; (89):108-21. PubMed ID: 1656929
[TBL] [Abstract][Full Text] [Related]
3. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
[TBL] [Abstract][Full Text] [Related]
4. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A
Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955
[TBL] [Abstract][Full Text] [Related]
5. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
[TBL] [Abstract][Full Text] [Related]
6. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
7. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis.
Seagon S; Dürst M
Cancer Res; 1994 Nov; 54(21):5593-8. PubMed ID: 7923202
[TBL] [Abstract][Full Text] [Related]
9. APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity.
Reuter S; Bartelmann M; Vogt M; Geisen C; Napierski I; Kahn T; Delius H; Lichter P; Weitz S; Korn B; Schwarz E
EMBO J; 1998 Jan; 17(1):215-22. PubMed ID: 9427755
[TBL] [Abstract][Full Text] [Related]
10. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
[TBL] [Abstract][Full Text] [Related]
11. Stabilization and reactivation of the p53 tumor suppressor protein in nontumorigenic revertants of HeLa cervical cancer cells.
Athanassiou M; Hu Y; Jing L; Houle B; Zarbl H; Mikheev AM
Cell Growth Differ; 1999 Nov; 10(11):729-37. PubMed ID: 10593649
[TBL] [Abstract][Full Text] [Related]
12. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
13. The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms.
Fogel S; Riou G
Virology; 1998 Apr; 244(1):97-107. PubMed ID: 9581783
[TBL] [Abstract][Full Text] [Related]
14. [Biological significance of HPV sequences integrated into cancer cells].
Tsunokawa Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):562-8. PubMed ID: 2539785
[TBL] [Abstract][Full Text] [Related]
15. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
16. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
Lathion S; Schaper J; Beard P; Raj K
Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
[TBL] [Abstract][Full Text] [Related]
17. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
[TBL] [Abstract][Full Text] [Related]
19. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
20. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
